Hormonal Diversity in Health and Diseases

A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cell Biology and Pathology".

Deadline for manuscript submissions: closed (31 July 2023) | Viewed by 1833

Special Issue Editor


E-Mail Website
Guest Editor
Department of Internal Medicine, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA
Interests: hormone regulation and function; endocrinology and reproductive biology; cellular biochemistry; protein-ligand interaction; signal transduction pathway; nutrition and immune function; aging and age-related diseases; cardiovascular diseases; Alzheimer’s disease and neuroprotection; hormone-sensitive cancers and their therapeutics
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Regulation of the hypothalamic–pituitary–thyroid–adrenal–gonadal (HPTAG) axis, involving a well-balanced endocrine circadian rhythmicity, is crucial to bodily homeostasis, and thus the proper functioning of a spectrum of physiological activities. Trophic hormones primarily govern the biosynthesis of steroid hormones that are produced from cholesterol, in which the steroidogenic acute regulatory protein (STAR) plays an indispensable role. There is a wealth of information supporting the fact that STAR influences a variety of cholesterol- and steroid-led events. Steroid hormones, functionally grouped into two categories: corticosteroids (glucocorticoids and mineralocorticoids) and sex steroids (androgens, progesterone, and estrogens), promote diverse processes, ranging from homeostasis to reproduction to neurodegeneration. Disruption in the HPTAG auto-regulatory system affects the functional efficacies of all organs, and results in a decline in the central nervous system and the endocrine system, involving an assortment of hormones. Hormone deficiencies modulate the immune system, develop into an array of physiological anomalies, and contribute to increased morbidity and mortality. These conditions profoundly affect geriatric populations. Senescence is the central hallmark of aging, and is triggered by numerous factors and/or events including epigenetic dysregulation, DNA damage, and dysfunction in mitochondrial networks, eventually leading to various health complications and diseases. Aging is also associated with a host of pathologies, including cancers (both hormone-dependent and hormone-independent), cardiovascular diseases, and neurodegenerative disorders related to cognitive impairment. Therapeutic approaches, involving hormonal equilibrium, immunomodulation, and pertinent drugs, are necessary to combat a variety of pathophysiological events for healthy living/aging. This Special Issue on the impacts of hormones on various physiological and pathophysiological aspects provides a venue for publishing both original research and review articles that enhance our understanding of fundamental cellular and molecular mechanisms in health and disease.  

Dr. Pulak Manna
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • hormone action and regulation
  • cholesterol transporters
  • steroid hormones and diverse activities
  • bodily homeostasis
  • reproductive capacity and function
  • hormonal imbalance
  • cardiovascular diseases
  • healthy aging
  • cancers
  • neurodegenerative disorders
  • pathophysiology and therapeutics

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

10 pages, 739 KiB  
Article
Association between Obesity, Race or Ethnicity, and Luminal Subtypes of Breast Cancer
by Kalhara R. Menikdiwela, Chanaka Kahathuduwa, Michelle L. Bolner, Rakhshanda Layeequr Rahman and Naima Moustaid-Moussa
Biomedicines 2022, 10(11), 2931; https://doi.org/10.3390/biomedicines10112931 - 15 Nov 2022
Cited by 7 | Viewed by 1464
Abstract
Luminal breast cancers are the most common genomic subtype of breast cancers where Luminal A cancers have a better prognosis than Luminal B. Exposure to sex steroids and inflammatory status due to obesity are key contributors of Luminal tumor development. In this study, [...] Read more.
Luminal breast cancers are the most common genomic subtype of breast cancers where Luminal A cancers have a better prognosis than Luminal B. Exposure to sex steroids and inflammatory status due to obesity are key contributors of Luminal tumor development. In this study, 1928 patients with Luminal A breast cancer and 1610 patients with Luminal B breast cancer were compared based on body mass index (BMI), age, race, menopausal status, and expressed receptors (i.e., estrogen (ER), progesterone (PR), and human epidermal growth factor receptor 2 (HER2)). Patients with Luminal B tumors had a significantly higher mean BMI (Δ = 0.69 kgm−2 [0.17, 1.21], p = 0.010) versus Luminal A. Interestingly, the risks of Luminal B tumors were higher among Black/African American patients versus White and Hispanic patients (p < 0.001 and p = 0.001, respectively). When controlled for each other, Black/African American race (p < 0.001) and increased BMI (p = 0.008) were associated with increased risks of Luminal B carcinoma, while postmenopausal status was associated with a decreased risk (p = 0.028). Increased BMI partially mediated the strong association between Black/African American race and the risk of Luminal B carcinoma. Thus, Black/African American race along with obesity seem to be associated with an increased risk of more aggressive Luminal B breast carcinomas. Full article
(This article belongs to the Special Issue Hormonal Diversity in Health and Diseases)
Show Figures

Figure 1

Back to TopTop